Chemoinformaics analysis of Pyroglutamylglutamine
| Molecular Weight | 257.246 | nRot | 6 |
| Heavy Atom Molecular Weight | 242.126 | nRig | 7 |
| Exact Molecular Weight | 257.101 | nRing | 1 |
| Solubility: LogS | -1.158 | nHRing | 1 |
| Solubility: LogP | -1.857 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 34.0119 |
| nHD | 4 | BPOL | 19.0901 |
| QED | 0.339 |
| Synth | 3.534 |
| Natural Product Likeliness | 0.157 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.434 |
| HIA | 0.054 |
| CACO-2 | -5.802 |
| MDCK | 0.00178459 |
| BBB | 0.911 |
| PPB | 0.0785307 |
| VDSS | 0.371 |
| FU | 0.856924 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.036 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.041 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.839 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.018 |
| CL | 3.62 |
| T12 | 0.753 |
| hERG | 0.018 |
| Ames | 0.018 |
| ROA | 0.002 |
| SkinSen | 0.071 |
| Carcinogencity | 0.026 |
| EI | 0.015 |
| Respiratory | 0.293 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.765624 |